menu
    • menu

    Company profile for DBV Technologies

    NEW Drugs in Dev: 7
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians and entrepreneurs who believed that food allergies could one day be treated safely and effectively. With this mission driving our commitment to the advancement of treatments in this field, we are investigating a potential new class of immunotherapy that aims to activate the immune system of patients through the skin.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    DBV TechnologiesFrance Flag
    Country
    Country
    France
    Address
    Address
    177-181 avenue Pierre Brossolette 92120 – Montrouge
    Telephone
    Telephone
    +33 (0)1 55 42 78 78
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.dbv-technologies.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dbv-technologies
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/dbvtechnologies?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    DBV Technologies Reports First Quarter 2026 Financial Results
    DBV Technologies Reports First Quarter 2026 Financial Results

    30 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7257146

    FIRSTWORD PHARMA
    30 Apr 2026
    Share Share
    DBV Technologies Unveils 2025 Financials And Business Progress
    DBV Technologies Unveils 2025 Financials And Business Progress

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3263464/0/en/DBV-Technologies-Reports-Full-Year-2025-Financial-Results-and-Business-Update.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    DBV Technologies Files 2025 Form 10-K And Registration Document
    DBV Technologies Files 2025 Form 10-K And Registration Document

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3263475/0/en/DBV-Technologies-Announces-Filing-of-2025-Annual-Report-on-Form-10-K-and-Universal-Registration-Document.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    DBV Technologies Enters CAC Mid 60 & SBF 120 Indices In Euronext
    DBV Technologies Enters CAC Mid 60 & SBF 120 Indices In Euronext

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261784/0/en/DBV-Technologies-to-Join-CAC-Mid-60-and-SBF-120-Indices-Following-Euronext-Paris-Annual-Review.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    DBV Technologies Joins March Investor Conferences
    DBV Technologies Joins March Investor Conferences

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249757/0/en/DBV-Technologies-to-Participate-in-Upcoming-March-Investor-Conferences.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    DBV Highlights VITESSE Phase 3 Data at 2026 AAAAI Meeting
    DBV Highlights VITESSE Phase 3 Data at 2026 AAAAI Meeting

    28 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/28/3246902/0/en/DBV-Technologies-Highlights-Additional-Data-from-Successful-Phase-3-VITESSE-Study-at-the-AAAAI-2026-Annual-Meeting.html

    GLOBENEWSWIRE
    28 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search